Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children.

Matone M, Localio R, Huang YS, dosReis S, Feudtner C, Rubin D.

Health Serv Res. 2012 Oct;47(5):1836-60. doi: 10.1111/j.1475-6773.2012.01461.x. Epub 2012 Sep 4.

2.

Treatment of Young People With Antipsychotic Medications in the United States.

Olfson M, King M, Schoenbaum M.

JAMA Psychiatry. 2015 Sep;72(9):867-74. doi: 10.1001/jamapsychiatry.2015.0500.

PMID:
26132724
3.

Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth.

Edelsohn GA, Karpov I, Parthasarathy M, Hutchison SL, Castelnovo K, Ghuman J, Schuster JM.

J Am Acad Child Adolesc Psychiatry. 2017 Jan;56(1):59-66. doi: 10.1016/j.jaac.2016.10.005. Epub 2016 Oct 24.

PMID:
27993230
4.

Atypical antipsychotic use among Medicaid-insured children and adolescents: duration, safety, and monitoring implications.

Burcu M, Zito JM, Ibe A, Safer DJ.

J Child Adolesc Psychopharmacol. 2014 Apr;24(3):112-9. doi: 10.1089/cap.2013.0094. Epub 2014 Apr 1.

PMID:
24690011
5.

Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.

Schröder C, Dörks M, Kollhorst B, Blenk T, Dittmann RW, Garbe E, Riedel O.

Eur Child Adolesc Psychiatry. 2017 Apr;26(4):413-420. doi: 10.1007/s00787-016-0905-7. Epub 2016 Sep 13.

PMID:
27623818
6.

Antipsychotic use by medicaid-insured youths: impact of eligibility and psychiatric diagnosis across a decade.

Zito JM, Burcu M, Ibe A, Safer DJ, Magder LS.

Psychiatr Serv. 2013 Mar 1;64(3):223-9. doi: 10.1176/appi.ps.201200081.

PMID:
23242390
7.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

8.

Use of administrative data to identify off-label use of second-generation antipsychotics in a Medicaid population.

Hartung DM, Middleton L, McFarland BH, Haxby DG, McDonagh MS, McConnell KJ.

Psychiatr Serv. 2013 Dec 1;64(12):1236-42. doi: 10.1176/appi.ps.005482012.

PMID:
23999754
9.

A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.

Ronsley R, Scott D, Warburton WP, Hamdi RD, Louie DC, Davidson J, Panagiotopoulos C.

Can J Psychiatry. 2013 Jun;58(6):361-9.

PMID:
23768264
10.

Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6 years old who received antipsychotic treatment in Florida's Medicaid program.

Constantine RJ, Tandon R, McPherson M, Andel R.

J Child Adolesc Psychopharmacol. 2011 Feb;21(1):79-84. doi: 10.1089/cap.2010.0068. Epub 2011 Feb 2.

PMID:
21288122
11.

Trends in Atypical Antipsychotics Prescribed to Children Six Years of Age or Less on Medicaid in Kentucky.

Lohr WD, Chowning RT, Stevenson MD, Williams PG.

J Child Adolesc Psychopharmacol. 2015 Jun;25(5):440-3. doi: 10.1089/cap.2014.0057. Epub 2015 Apr 21.

12.

State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia.

Brown JD, Barrett A, Caffery E, Hourihan K, Ireys HT.

Psychiatr Serv. 2014 Jan 1;65(1):121-4. doi: 10.1176/appi.ps.201300001.

PMID:
24382765
14.

Access to Psychosocial Services Prior to Starting Antipsychotic Treatment Among Medicaid-Insured Youth.

Finnerty M, Neese-Todd S, Pritam R, Leckman-Westin E, Bilder S, Byron SC, Hudson Scholle S, Crystal S, Olfson M.

J Am Acad Child Adolesc Psychiatry. 2016 Jan;55(1):69-76.e3. doi: 10.1016/j.jaac.2015.09.020. Epub 2015 Oct 14.

15.

Clonidine utilization trends for Medicaid children.

Yoon EY, Cohn L, Rocchini A, Kershaw D, Clark SJ.

Clin Pediatr (Phila). 2012 Oct;51(10):950-5. doi: 10.1177/0009922812441661. Epub 2012 Apr 17.

16.

Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004.

Depp C, Ojeda VD, Mastin W, Unützer J, Gilmer TP.

Psychiatr Serv. 2008 Oct;59(10):1169-74. doi: 10.1176/appi.ps.59.10.1169.

PMID:
18832503
17.

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Comer JS, Olfson M, Mojtabai R.

J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1001-10. doi: 10.1016/j.jaac.2010.07.007. Epub 2010 Sep 1.

18.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
19.

New users of antipsychotic medications among children enrolled in TennCare.

Cooper WO, Hickson GB, Fuchs C, Arbogast PG, Ray WA.

Arch Pediatr Adolesc Med. 2004 Aug;158(8):753-9.

PMID:
15289247
20.

Prescribing of antipsychotics in UK primary care: a cohort study.

Marston L, Nazareth I, Petersen I, Walters K, Osborn DP.

BMJ Open. 2014 Dec 18;4(12):e006135. doi: 10.1136/bmjopen-2014-006135.

Supplemental Content

Support Center